Simultaneous separation and determination of isosorbide dinitrate and isosorbide 5-mononitrate in human plasma by LC-MS-MS

Chromatographia

Volumn 71, Issue 7-8, 2010, Pages 595-602

  Kim, Hohyun ^a,c   Lee, Jae Yong ^b,c   Song, Ki Seob ^c   Seo, Young Hwan ^a,c   Park, So Young ^d   Kim, Kyeong Ho ^b   Je, Hyun Dong ^e   Han, Sang Beom ^a   Jeong, Ji Hoon ^a  

^a Chung Ang University   (South Korea)

^b Kangwon National University   (South Korea)

^c Seoul Pharma Co Ltd   (South Korea)

^d Korea University College of Medicine   (South Korea)

^e Catholic University of Daegu   (South Korea)

Author keywords

Column liquid chromatography; Isosorbide dinitrate and isosorbide 5 mononitrate; Pharmacokinetic study; Tandem mass spectrometry

Indexed keywords

ACETIC ACID ETHYL ESTER; ISOSORBIDE 5 NITRATE; ISOSORBIDE DINITRATE; TOPIRAMATE;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG HALF LIFE; DRUG STABILITY; DRUG STRUCTURE; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; METABOLITE; NORMAL HUMAN; PH MEASUREMENT; PHASE SEPARATION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PRODUCT RECOVERY; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

EID: 77952890744     PISSN: 00095893     EISSN: 16121112     Source Type: Journal    
DOI: 10.1365/s10337-010-1480-6     Document Type: Article

References (12)

1. R Berlin 1987 Drugs 33 Suppl 4 1 4 10.2165/00003495-198700334-00003
2. UE Jonsson 1987 Drugs 33 Suppl 4 23 31 10.2165/00003495-198700334-00006 1:CAS:528:DyaL2sXls1Wnt7o%3D
3. G Nyberg 1994 Am J Ther 1 93 101 10.1097/00045391-199406000-00015
4. F Pommier N Gauducheam V Pineau A Sioufi J Godbillon 1996 J Chromatogr B 678 354 359 10.1016/0378-4347(95)00570-6 1:CAS:528:DyaK28XjtFeit7s%3D (Pubitemid 26168672)
5. J Pastera L Vyslouzil J Kvetina 2004 J Chromatogr B 800 271 274 10.1016/j.jchromb.2003.10.069 1:CAS:528:DC%2BD3sXhtVSjtbrK (Pubitemid 38041034)
6. C Lauro-Marty C Lartique-Mattei JL Chabard E Beyssac JM Aiache M Nadesclaire 1995 J Chromatogr B 663 153 159 10.1016/0378-4347(94)00436-9 1:CAS:528:DyaK2MXjt1Sks7g%3D
7. A Stockis S De Bruyn X Deroubaix B Jeanbaptiste E Lebacq Jr F Nollevaux G Poli D Acerbi 2002 Eur J Pharm Biopharm 53 49 56 10.1016/S0939-6411(01)00210-7 1:CAS:528:DC%2BD38XltFCj (Pubitemid 34036997)
8. TB Vree E Dammers R Valducci 2004 Int J Clin Pharmacol Ther 42 463 472 1:CAS:528:DC%2BD2cXntVyhu7c%3D
9. LC Silva LS Oliveira GD Mendes G Garcia S Pereira Ados G De Nucci 2006 J Chromatogr B 832 302 306 10.1016/j.jchromb.2005.12.027 1:CAS:528: DC%2BD28XitVehsrs%3D (Pubitemid 43339962)
10. X Sun X Li S Cai F Qin X Lu F Li 2007 J Chromatogr B Analyt Technol Biomed Life Sci 846 323 328 10.1016/j.jchromb.2006.08.022 1:CAS:528: DC%2BD2sXhtVKgtr8%3D (Pubitemid 46149493)
11. DS Jain G Subbaiah M Sanyal PS Shrivastav U Pal S Ghataliya A Kakad J Bhatt V Munjal H Patel S Shah 2006 Rapid Commun Mass Spectrom 20 2921 2931 10.1002/rcm.2684 1:CAS:528:DC%2BD28XhtVylsr%2FK (Pubitemid 44526631)
12. Guidance for industry, Bioanalytical method validation, US Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research (CDER), Center for veterinary Medicine (CVM), May 2001